Lv1
30 积分 2026-01-06 加入
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap
16小时前
求助中
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
19小时前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
5天前
已完结
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
25天前
已完结
Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis
25天前
已完结
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
25天前
已完结
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
25天前
已完结
Evaluation of efficacy and tolerability of first-line therapies in NMOSD
25天前
已完结
Extrafollicular and Other Non-Germinal Center B Cell Responses: An Evolutionary Perspective
25天前
已完结
Multiple sclerosis: a smoldering disease
26天前
已完结
皖公网安备34019202002308
